» Articles » PMID: 25004062

Neutrophil Extracellular Traps in Sepsis

Overview
Journal Shock
Date 2014 Jul 9
PMID 25004062
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis is the leading cause of death in critically ill patients in intensive care units. Early recognition of sepsis and proper therapy are essential to reduce patient mortality. Moreover, treatment options for this deleterious inflammatory response to infection are limited. Neutrophils play an essential role in the innate immune response, providing the first line of host defense. It has recently been shown that these cells can trap and kill microorganisms by releasing neutrophil extracellular traps (NETs) composed of chromatin and antimicrobial proteins. Although the beneficial role of NETs during infections has been demonstrated, there is increasing evidence that NETs and their components contribute to the pathogenesis of several diseases, including sepsis. The aim of this review was to summarize the current evidence implicating NETs, as well as their components, in the development of sepsis and to discuss their potential use as novel therapeutic targets and as prognostic markers in septic patients.

Citing Articles

Histological Findings of ETosis in Hermansky-Pudlak Syndrome with Pulmonary Fibrosis: A Follow-Up Case Report.

Navarro S, Ashrani A, Park M, Chen D J Chest Surg. 2024; 58(1):46-49.

PMID: 39434611 PMC: 11738137. DOI: 10.5090/jcs.24.059.


Elevated circulating levels of neutrophil extracellular traps after cardiopulmonary bypass surgery as risk factors of postoperative atrial fibrillation and mortality.

Jung Y, Choi J, Hwang H, Gu J, Kim K, Kim H J Thorac Dis. 2024; 16(7):4319-4328.

PMID: 39144365 PMC: 11320234. DOI: 10.21037/jtd-24-295.


The Relationship Between Acute Kidney Injury in Sepsis Patients and Coagulation Dysfunction and Prognosis.

Wang Z, Dong S, Qin Y Open Access Emerg Med. 2024; 16:145-157.

PMID: 38979546 PMC: 11228537. DOI: 10.2147/OAEM.S453632.


Neonatal NET-inhibitory factor inhibits macrophage extracellular trap formation.

Bircher J, Denorme F, Cody M, de Araujo C, Petrey A, Middleton E Blood Adv. 2024; 8(14):3686-3690.

PMID: 38810257 PMC: 11284700. DOI: 10.1182/bloodadvances.2024013094.


CD5L as a promising biological therapeutic for treating sepsis.

Oliveira L, Silva M, Gomes A, Santos R, Cardoso M, Novoa A Nat Commun. 2024; 15(1):4119.

PMID: 38750020 PMC: 11096381. DOI: 10.1038/s41467-024-48360-8.